To better your understanding of non-clinical career options and/or facilitate your physician career change, today we introduce you to Deborah Dunsire, MD. Dr. Dunsire joined Millennium in July, 2005 with nearly 20 years of experience in commercial, operational, clinical and scientific aspects of a world-leading pharmaceutical business. Her vision for Millennium is to establish a vibrant, growing biotechnology company, which discovers and develops new medicines that change standards of care in cancer and inflammation.
Previously, Dr. Dunsire led the Novartis U.S. Oncology business and played a critical role in the broad development and launch of successful products such as Zometa®, Femara® and Gleevec®. Notably, Dr. Dunsire managed 12 product launches and built the business from approximately $50 million to $2.1 billion in revenues over 10 years. Dr. Dunsire also was responsible in the U.S. for managing the merger and significant growth of the combined Sandoz Pharmaceuticals and Ciba-Geigy oncology businesses. Earlier in her career, she was a clinical researcher responsible for the implementation of global Phase II and Phase III studies across multiple therapeutic areas, including immunology, endocrinology, neurology, dermatology, oncology and transplantation.
Dr. Dunsire graduated from medical school at the University of Witwatersand in Johannesburg, South Africa. In 2006, she was also awarded a Doctor of Science, Honoris Causa, from Worcester Polytechnic Institute. Currently, Dr. Dunsire is a board member of the Pharmaceutical Research and Manufacturers of America (PhRMA), Biotechnology Industry Organization (BIO), Allergan, Inc. and the G&P Foundation for Cancer Research. In 2001, she was the recipient of the American Cancer Society Excalibur award, the 2000 recipient of the Health Care Business Women’s Association Rising Star award and also the Creative Spirit award from the Creative Center for Women with Cancer.
This biography is available on the Millennium Pharmaceuticals website. For more information about Dr. Dunsire and Millennium Pharmaceuticals, please visit their website.
